Welcome to our dedicated page for Sabra Health Care Reit SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sabra Health Care REIT, Inc. filings document the reporting obligations of a Nasdaq-listed healthcare REIT that owns and invests in healthcare real estate through subsidiaries. Its 8-K reports cover operating results, supplemental information packages, non-GAAP financial measure reconciliations, Regulation FD materials, capital-structure events and material definitive agreements.
Proxy materials describe board and shareholder governance for the Maryland corporation. Other disclosures address common stock listed under the SBRA symbol, equity distribution arrangements, debt redemption notices, related financing arrangements and risk or governance matters tied to the company’s REIT structure and healthcare real estate portfolio.
Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Jeffrey A. Malehorn received an equity grant of 8,310 restricted stock units of common stock as compensation. The award was granted under Sabra’s 2009 Performance Incentive Plan and carries no purchase price.
The units vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. After this grant, Malehorn has beneficial ownership of 116,346 shares/units, including 8,310 unvested stock units and 55,016 stock units that have vested but with payment deferred, each unit representing one share of common stock.
Kono Ann reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Ann Kono received an equity award of 8,310 restricted stock units of common stock as compensation. The grant was made at no cash cost to her and is structured to vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders' meeting.
Each unit represents the right to receive one share of Sabra’s common stock. Following this grant, Kono has an aggregate 68,186 stock units, including the 8,310 unvested units from this award and 55,016 units that have already vested but for which share delivery has been deferred.
KATZMANN LYNNE S reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 8,310 restricted stock units of Common Stock at no cash cost, as part of the company’s 2009 Performance Incentive Plan. These units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.
Each stock unit represents the right to receive one share of common stock. Following this award, Katzmann directly holds 86,121 stock units, including 8,310 unvested units and 55,016 units that have vested but for which payment has been deferred.
FOSTER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Michael J. Foster reported a new equity award and updated holdings. He received a grant of 8,310 shares of common stock as a restricted stock unit award at a stated price of $0.00 per share, increasing his direct ownership to 82,043 shares after the award. The units were granted under the company’s 2009 Performance Incentive Plan and will vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. The filing also shows 42,411.745 shares held indirectly through a 401(k) plan and notes that his equity mix includes 8,310 unvested stock units and 55,016 vested but deferred stock units, each representing the right to receive one share of common stock.
Cusack Catherine reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Catherine Cusack received a grant of 8,310 restricted stock units of Common Stock. The grant was made at no cash cost per share and increases her direct holdings to 82,056 shares and stock units in total following the transaction.
The restricted stock units were granted under Sabra’s 2009 Performance Incentive Plan. According to the terms, they vest in equal monthly installments beginning on July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.
Footnote disclosure indicates her holdings include 8,310 unvested stock units from this grant and 55,016 stock units that have already vested but for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s Common Stock.
Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Craig A. Barbarosh reported an equity compensation grant rather than an open-market trade. He received 8,310 restricted stock units of common stock under the company’s 2009 Performance Incentive Plan at no cash cost.
The units vest in equal monthly installments beginning July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. Following this grant, he holds 63,326 stock units directly, consisting of 8,310 unvested units and 55,016 vested units with payment deferred, each representing one share of common stock. He also reports 94,916 shares held indirectly through The Barbarosh Family Trust.
Sabra Health Care REIT, Inc. held its annual stockholder meeting on June 17, 2026. Stockholders elected seven directors to serve until the 2027 annual meeting and until their successors are elected and qualified.
They also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026, with 226,576,585 votes for, 1,648,639 against and 173,917 abstentions. In addition, stockholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 199,568,777 votes for, 7,867,562 against and 355,123 abstentions.
Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Jeffrey A. Malehorn received 817 stock units as a compensation-related award. The units were credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan, with no cash paid by Malehorn. These new units vest and pay on the same schedule as the original awards.
After this grant, Malehorn directly holds 108,036 stock units or shares-linked units, including 726 unvested stock units and 54,290 vested stock units whose payment has been deferred. Each stock unit represents the right to receive one share of Sabra common stock.
Kono Ann reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Ann Kono received an award of 817 common stock units on May 29, 2026. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.
Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same schedule as the original awards. Following this grant, Kono directly holds 59,876 stock units, including 726 unvested units and 54,290 vested units for which payment has been deferred.
Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 817 stock units of common stock on May 29, 2026. The award was credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carries no cash exercise price.
Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same terms as the original units they relate to. After this credit, Katzmann holds 77,811 stock units in total, including 726 unvested units and 54,290 vested units with payment deferred.